Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation.

about

Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation.

Item

http://www.wikidata.org/entity/Q38847015

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Bortezomib and fenretinide ind ...... nd IκBα kinase downregulation.

@en

type

Item

label

Bortezomib and fenretinide ind ...... nd IκBα kinase downregulation.

@en

prefLabel

Bortezomib and fenretinide ind ...... nd IκBα kinase downregulation.

@en

P1476

Bortezomib and fenretinide ind ...... and IκBα kinase downregulation

@en

P2093

Andrew J Cowan

http://www.w3.org/2001/XMLSchema#string

Damian J Green

http://www.w3.org/2001/XMLSchema#string

John M Pagel

http://www.w3.org/2001/XMLSchema#string

Maria C Palanca-Wessels

http://www.w3.org/2001/XMLSchema#string

Shani L Frayo

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project

A decade of molecular biology of retinoic acid receptors

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma.

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation

Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma

Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma

Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma.

Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human beta-defensin 3 in skin keratinocytes

P304

974-983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CAD.0000000000000274

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ajay K Gopal

Oliver W Press

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26237500

http://www.w3.org/2001/XMLSchema#string

P932

4545689

http://www.w3.org/2001/XMLSchema#string